Delivery Order SPE2DB24D1034-SPE2DB24FWAD8
Award Date 5/30/24
Potential Completion Date 5/31/24
Potential Value $1.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is a delivery order valued at $2,613.14 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RABAVERT Rabies Vaccine with diluents, with a period of performance through May 31, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract, valued at $1,544.24, is a Delivery Order for the supply of RABAVERT Rabies Vaccine with diluents. This contract does not have a set-aside designation. Amerisourcebergen holds two Indefinite Delivery Contracts (IDCs) related to the provision of pharmaceutical...
- This federal contract award, valued at $5,819.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of RABAVERT RABIES VACC W-DILUENTS, a critical pharmaceutical product, with a performance period through April 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) is for the delivery of RABAVERT rabies vaccine vials with diluents. The contract has a ceiling value of $1,930.30 and an ultimate completion date of April 17, 2024. This is a Firm Fixed Price delivery order contract with no set-aside designation. Amerisourcebergen is a major pharmaceutical distribution company that holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $9,651.50 to provide RABAVERT rabies vaccine with diluents. This award is part of Amerisourcebergen's broader contract vehicle with DLA, an indefinite delivery contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, to deliver a wide range of pharmaceutical products and medical supplies to DLA Troop...
- This federal contract award for $32,207.80 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of RABAVERT rabies vaccine with diluents, under a Firm Fixed Price Delivery Order. The award has a completion date of June 17, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $8,945.46 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of RABAVERT RABIES VACC W-DILUENTS and has an ultimate completion date of May 10, 2024. This order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary...
- This federal contract award, valued at $1,351.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of RABAVERT RABIES VACC W-DILUENTS, a pharmaceutical product, with a performance period ending on July 12, 2024. The contract has a firm-fixed-price pricing type and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The firm fixed-price delivery order, valued at $12,017.42, has an ultimate completion date of June 27, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of RABAVERT rabies vaccines with diluents, valued at $5,790.90. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. Amerisourcebergen, a major pharmaceutical distribution company, holds several indefinite delivery contracts (IDCs) with the federal government, including a single-award IDC with the DLA Troop Support Medical...